The Future of European Pharmaceutical Distribution

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Aesica Pharmaceuticals Limited SWOT Analysis, Strategy, Revenues and Profits

Aesica Pharmaceuticals Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • September 2014
  • 31 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pharmaceutical | Countries: Italy, Germany, China, Switzerland, Austria, Europe, United States

H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review

H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • by Global Data
  • September 2014
  • 51 pages

H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the ...

Industries: Pathology | Countries: Denmark, Europe

Turkey Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Turkey Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • September 2014
  • 123 pages

BMI View: While many innovative pharmaceutical companies have identified pricing policies and weaknesses in Turkey’s intellectual property (IP) framework as key challenges that will continue to deter further capital investment in the industry, Turkey’s macroeconomic conditions remain highly favourable. ...

Industries: Drug and Medication | Countries: Turkey, Europe, United States

Erectile Dysfunction - Pipeline Review, H2 2014

Erectile Dysfunction - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • August 2014
  • 101 pages

Erectile Dysfunction - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Erectile Dysfunction - Pipeline Review, H2 2014', provides an overview of the Erectile Dysfunction's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Erectile Dysfunction, ...

Industries: Drug Discovery and Development | Countries: World, United Kingdom, Europe

Future Horizons and Growth Strategies in the European Tumor Marker Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the European Tumor Marker Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 12 800
  • Industry report
  • by Venture Planning Group
  • August 2014
  • 820 pages

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five ...

Industries: Pathology | Countries: Europe

Dechra Pharmaceuticals plc (Symbol:DPH) SWOT Analysis, Strategy, Revenues and Profits

Dechra Pharmaceuticals plc (Symbol:DPH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Dechra Pharmaceuticals plc SWOT Analysis report provides you a strategic ...

Industries: Pharmaceutical | Countries: Europe, United Kingdom, World, United States, Netherlands

Italfarmaco S.p.A. SWOT Analysis, Strategy, Revenues and Profits

Italfarmaco S.p.A. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pharmaceutical | Countries: Italy, Europe, Switzerland, Chile, Spain, Russian Federation, Portugal, Greece, World

PHOENIX Group SWOT Analysis, Strategy, Revenues and Profits

PHOENIX Group SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pharmacies and Drug Stores | Countries: Europe, Czech Republic, Germany, Sweden, Slovakia (slovak Republic), Italy, Finland, Denmark, Bulgaria, World, Switzerland, Netherlands, Norway, Hungary, Croatia, Bosnia and Herzegovina, Serbia and Montenegro

PLIVA d.d. SWOT Analysis, Strategy, Revenues and Profits

PLIVA d.d. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pharmaceutical | Countries: Serbia and Montenegro, Croatia, Europe, Macedonia, Bosnia and Herzegovina, Albania

Recordati S.p.A. (Symbol:REC) SWOT Analysis, Strategy, Revenues and Profits

Recordati S.p.A. (Symbol:REC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Recordati S.p.A. SWOT Analysis report provides you a strategic analysis ...

Industries: Pharmaceutical | Countries: Czech Republic, Germany, Europe

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.